Viriom Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $4.7M
Latest Deal Amount
  • Investors
  • 3

Viriom General Information

Description

Developer of a biotechnology platform designed to focus on pharmaceuticals for treating certain viruses. The company's platform offers affordable therapies against life-threatening infections such as HIV (human immunodeficiency virus) and Hepatitis B virus and has developed a proprietary pre-clinical lead compound as a potentially curative treatment of chronic HBV, enabling physicians to treat their patients in an enhanced way.

Contact Information

Website
www.viriom.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • 12760 High Bluff Drive
  • Suite 370
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Viriom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 11-May-2016 $4.7M 00.000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Viriom’s complete valuation and funding history, request access »

Viriom Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biotechnology platform designed to focus on pharmaceuticals for treating certain viruses. The company's p
Pharmaceuticals
San Diego, CA
4 As of 2016
00.000
0000000000 0 00.000

0000000

olore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
0000000000000
Framingham, MA
0 As of 0000
000.00
000000000 000.00

00000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000
Mountain View, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viriom Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xenetic Bioscience Corporation Framingham, MA 0 000.00 000000000 000.00
000000000000 Formerly VC-backed Mountain View, CA 000 00000 000000 - 000 00000
000000000 00000000 Formerly VC-backed Charlottesville, VA 00 000.00 00000000 000.00
0000000 Formerly Angel backed Vancouver, WA 00 00000 000000000 00000
00000000 Formerly VC-backed Sunnyvale, CA 0 00.000 00000000000 00.000
You’re viewing 5 of 37 competitors. Get the full list »

Viriom Executive Team (7)

Name Title Board Seat Contact Info
Ronald Demuth Board Member & Chief Financial Officer
Robert Murphy MD Advisor & CMO
Vladimir Kan Ph.D CBO
Oleg Korzinov Board Member & Vice President, Development
Iain Dukes Ph.D Chief Executive Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Viriom Board Members (7)

Name Representing Role Since
Augustine Lawlor Viriom Board Member 000 0000
Jennifer Cayer Viriom Board Member 000 0000
Milos Petrovic Viriom Board Member & Scientific Advisor 000 0000
Nikolay Merkin Self Board Member 000 0000
Nikolay Savchuk Ph.D Torrey Pines Investment Chairman & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Viriom Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viriom Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ChemRar High Tech Center Corporation Minority 000 0000 000000 0
Skolkovo Foundation Limited Partner 000 0000 000000 0
Torrey Pines Investment Venture Capital Minority 000 0000 000000 0
To view Viriom’s complete investors history, request access »